Structure |
Chemical Name |
CAS |
MF |
|
Uridine, 5'-(2-methylpropanoate) (9CI) |
886538-48-3 |
C13H18N2O7 |
|
Dapagliflozin Impurity 47 |
|
|
|
Crisaborole Impurity 17 |
|
|
|
Crisaborole Impurity 19 |
|
|
|
1,5-Pentanedione, 1-(2-fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-3-oxazolidinyl]- |
2514695-40-8 |
C20H18FNO4 |
|
4-ethoxy-3-(4-pyridyl)-3-buten-2-one |
88349-61-5 |
C11H13NO2 |
|
Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)propoxy]methyl]- (9CI) |
107021-20-5 |
C9H14N5O4P |
|
Sitagliptin EP Impurity 7 |
|
|
|
Sitagliptin EP Impurity H |
|
|
|
7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-3-hydroxy-N-[1-(3-methoxypropyl)-4-piperidinyl]- |
2636673-48-6 |
C18H26ClN3O4 |
|
Beprostatin impurity 4 |
|
|
|
cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole |
65621-78-5 |
C17H16ClNO |
|
methyl tosylcarbamate |
14437-03-7 |
C9H11NO4S |
|
(1R,2R,4S,5S,7s,9r)-9-butyl-9-methyl-7-((2-phenylacryloyl)oxy)-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium |
786598-71-8 |
C21H28NO3+ |
|
(+)-2-Ethoxy-4-(N-3-Methyl-1(S)-(2-(1-Piperidinyl)Phenyl)-Butyl)Carbamoylmethyl) |
147770-06-7 |
C29H40N2O4 |
|
4-Chloro-2-(chloromethyl)-3-Methyl Pyridine Hydrochloride |
152402-97-6 |
C7H8Cl3N |
|
4-(3-CYANO-2-METHYLPROPIONYL)ACETAMILIDE |
42075-21-8 |
|
|
Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime] |
119699-81-9 |
C48H94N2O14Si2 |
|
Bimatoprost Impurity 11 |
|
|
|
Bimatoprost Impurity 9 |
|
|
|
Dolutegravir Impurity 18 |
|
|
|
PeraMpanel |
380918-53-6 |
C23H15N3O |
|
Lenvatinib Impurity 33 |
|
|
|
isopropyl 2-(2-oxopyrrolidin-1-yl)acetate |
1249080-59-8 |
C9H15NO3 |
|
Pitavastatin Impurity 71 |
|
|
|
Rosuvastatin EP Impurity M Sodium Salt |
|
|
|
Furosemide impurity 8 |
|
|
|
Febuxostat Impurity 108 |
|
|
|
Flucloxacillin EP Impurity J |
|
|
|
Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, mono[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl] ester |
1878175-77-9 |
C17H23N10O4P |
|
Acetic acid, 2-[[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]amino]-2-oxo-, ethyl ester |
480450-85-9 |
C21H31N5O5S |
|
3H-Oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid, 1b-(4-fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-, (βR,3R)- |
1193817-52-5 |
C33H35FN2O7 |
|
Hexanoic acid, 3-formyl-, ethyl ester |
54374-02-6 |
C9H16O3 |
|
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)- |
154877-92-6 |
C9H16O5 |
|
INDEX NAME NOT YET ASSIGNED |
2463617-49-2 |
C51H56N16O4 |
|
Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]- |
906673-43-6 |
C14H11BO5 |
|
Benzenemethanamine, α,α'-sulfonylbis(methylene)bis[3-ethoxy-4-methoxy- |
2417213-71-7 |
C22H32N2O6S |
|
1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- |
2138805-26-0 |
C25H29ClN8O2 |
|
1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo- |
1651211-78-7 |
C19H27I2N3O9 |
|
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
|
|
(R)-8-(3-aminopiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-(3-oxobutyl)-3,7-dihydro-1H-purine-2,6-dione |
|
|
|
Isavuconazole Impurity 37 |
|
|
|
"mixture of 2-amino-9-[[2-(hydroxymethoxy) ethoxy]methyl]-1,9-dihydro-6H-purin-6-one and 2-amino-9-[[2-(hydroxyethoxy)methoxy]methyl]-1,9- dihydro-6H-purin-6-one," |
|
|
|
N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide |
1375004-39-9 |
C29H39BN4O4 |
|
(S)-1-(2-(((1r,3R,5S,7S)-3,5-dihydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile |
|
|
|
Mannitol EP impurity B |
|
|
|
Mannitol EP impurity A |
|
|
|
Peramivir Amino Carboxylic Isomerism Impurity |
|
|
|
Peramivir Chlorinated Impurity |
|
|
|
Brivaracetam Impurity 999 |
|
|
|
Dasatinib impurity 48 |
|
|
|
Pemetrexed Impurity 120 |
|
|
|
Ticagrelor Impurity 101 |
|
|
|
4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane |
|
|
|
Donepezil Impurity 3 |
1023500-88-0 |
C24H27NO4 |
|
Fesoterodine Related Impurity 4 |
214601-12-4 |
C22H29NO2 |
|
Prasugrel Impurity 14 Maleate |
1373350-60-7 |
C24H25BrFNO7S |
|
Sofosbuvir Impurity 32 |
1157884-58-6 |
C20H17FO6 |
|
Torsemide Related Compound 1 |
947327-54-0 |
C13H13N3O2S |
|
Vortioxetine Impurity 3 |
508233-82-7 |
C17H20N2S |
|
CYCLOPENTYL BENZOATE |
32651-38-0 |
C12H14O2 |
|
D(-)-AMETHOPTERIN |
51865-79-3 |
C20H22N8O5 |
|
(E)-1-(4-(2-carboxyvinyl)benzyl)-1H-imidazole 3-oxide |
|
|
|
Aprepitant impurity 2 |
|
|
|
Aprepitant impurity 4 |
|
|
|
Vonoprazan Impurity B-2 |
|
|
|
2-(Cyanomethylthio)acetic acid |
55817-29-3 |
C4H5NO2S |
|
2(1H)-Pyridinone, 1-(3-aminophenyl)-5,6-dihydro-3-(4-morpholinyl)- |
2437650-75-2 |
C15H19N3O2 |
|
4(1H)-Pyridinone, 1-(6-methoxy-1H-benzimidazol-2-yl)-2,3,5-trimethyl- |
2512216-37-2 |
C16H17N3O2 |
|
Budesonide Impurity 31 |
|
|
|
Budesonide Impurity 23 |
|
|
|
Hexanoic acid, 3-(chloromethyl)-, (3R)- |
2101641-90-9 |
C7H13ClO2 |
|
Bisoprolol Impurity |
2226263-68-7 |
C18H31NO4 |
|
2(1H)-Quinolinone, 5-[(1R)-1,2-dihydroxyethyl]-8-(phenylmethoxy)- |
1261219-83-3 |
C18H17NO4 |
|
Tofacitinib Impurity |
2504210-41-5 |
C29H38N10O2 |
|
tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate |
|
|
|
2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)- |
2459302-85-1 |
C21H27N7O3 |
|
Avatrombopag Impurity 38 |
|
|
|
(1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) |
96946-55-3 |
C53H72N2O12+2 |
|
Glycine, N-(2-aminobenzoyl)-, ethyl ester |
5973-34-2 |
C11H14N2O3 |
|
6-Chloro-3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzoxanine-8-carboxylic acid |
123040-79-9 |
C10H8ClNO4 |
|
3-Amino-3-azabicyclo[3.3.0]octane |
54528-00-6 |
C7H14N2 |
|
(S)-Methyl 2-aminobutanoate |
15399-22-1 |
C5H11NO2 |
|
(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
|
|
|
(3aS-cis)-1,3-dibenzyltetrahydro-1H-thieno[3,4-d]imidazole-2,4-dione |
28092-52-6 |
C19H18N2O2S |
|
methyl L-prolinate |
2577-48-2 |
C6H11NO2 |
|
sodium (S,Z)-2-((1S,2R)-1-carboxylato-2-hydroxypropyl)-5-(4- hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylate |
|
|
|
3-(((3R)-3-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-2-(4-fluorophenyl)-1,4-dioxan-2-ylamino)methyl)-1H-1,2,4-triazol-5(4H)-one |
|
|
|
2,4,6-tripropyl-1,3,5-trioxane |
2396-43-2 |
C12H24O3 |
|
3-amino-5-[(methylthio)methyl]oxazolidin-2-one |
25517-72-0 |
C5H10N2O2S |
|
1-(3-((2,4-dimethylphenyl)thio)phenyl)piperazine hydrochloride |
2137793-92-9 |
|
|
Apixaban impurity 66S |
|
|
|
Aatrombopag Impurity 17 |
1268118-96-2 |
C7H4BrClN2S2 |
|
(R)-(-)-2-AMINOBUTANAMIDE HYDROCHLORIDE, 97% |
103765-03-3 |
C4H11ClN2O |
|
Flomoxef Impurity 20 Sodium Salt |
2095697-77-9 |
C15H18F2N6O7S2 |
|
((2R,3S,4R)-3,4,5-trihydroxytetrahydrofuran-2-yl)methyl isobutyrate |
2591381-21-2 |
C9H16O6 |
|
3-Thiophenecarboxylic acid, 4-(bromomethyl)-2-[[(2,6-difluorophenyl)methyl](propoxycarbonyl)amino]-5-(4-nitrophenyl)-, ethyl ester |
2591260-07-8 |
C25H23BrF2N2O6S |
|
Cyclohexanecarboxylic acid, 2-[[[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]amino]carbonyl]-, (1R,2S)-rel- |
190582-37-7 |
C23H32N4O3S |
|
Ivabradine Impurity II |
|
|
|
(1R,2R,4S,5S,7r)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate |
792155-94-3 |
C18H19NO4S2 |